Li–Fraumeni syndrome
| Li–Fraumeni syndrome | |
|---|---|
| Other names | Sarcoma family syndrome of Li and Fraumeni, SBLA |
| Li–Fraumeni syndrome is inherited via an autosomal dominant manner | |
| Specialty | Oncology, medical genetics, neurology |
Li–Fraumeni syndrome (LFS) is a rare, autosomal dominant, hereditary disorder that predisposes carriers to cancer development. It was named after two American physicians, Frederick Pei Li and Joseph F. Fraumeni Jr., who first recognized the syndrome after reviewing the medical records and death certificates of childhood rhabdomyosarcoma patients. The disease is also known as SBLA, for the Sarcoma, Breast, Leukemia, and Adrenal Gland cancers that it is known to cause.